MG-132 463518 Smiles: NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1C=CC(Cl)=CC=1

Smiles: NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1C=CC(Cl)=CC=1

J Clin Invest

Metastatic Castration-Resistant Prostate Cancer: Critical Review of MDV-3100

validating IKK-2 as a potential anti-inflammatory drug target in vivo

MG-132 463518 Smiles: NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1C=CC(Cl)=CC=1MG132 is a specific, potent, reversible, and cell permeable proteasome inhibitor (Ki = 4 nM) . It reduces the degradation of ubiquitin conjugated proteins in mammalian cells and permeable strains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. MG132 activates c Jun N terminal kinase (JNK1), which initiates apoptosis. MG132 also inhibits NF B activation with an IC50 of 3 M and prevents secretase cleavage. MG 132